As of 2024-12-11, the Relative Valuation of ImmunoGen Inc (IMGN) is (6.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on Relative Valuation is -119.6%.
The range of the Relative Valuation is (5.71) - (5.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 31.7x | 26.7x |
| Forward P/E multiples | 19.2x - 20.3x | 19.8x |
| Fair Price | (5.71) - (5.33) | (6.11) |
| Upside | -118.3% - -117.1% | -119.6% |
| Date | P/E |